NO2006005I2 - Difteri-,tetanus-, acellulære kikhoste- og polioantigener - Google Patents

Difteri-,tetanus-, acellulære kikhoste- og polioantigener

Info

Publication number
NO2006005I2
NO2006005I2 NO2006005C NO2006005C NO2006005I2 NO 2006005 I2 NO2006005 I2 NO 2006005I2 NO 2006005 C NO2006005 C NO 2006005C NO 2006005 C NO2006005 C NO 2006005C NO 2006005 I2 NO2006005 I2 NO 2006005I2
Authority
NO
Norway
Prior art keywords
tetanus
diphtheria
whooping cough
polio antigens
acellular whooping
Prior art date
Application number
NO2006005C
Other languages
English (en)
Other versions
NO2006005I1 (no
Original Assignee
Glaxosmithkline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline filed Critical Glaxosmithkline
Publication of NO2006005I1 publication Critical patent/NO2006005I1/no
Publication of NO2006005I2 publication Critical patent/NO2006005I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO2006005C 1996-11-07 2006-04-25 Difteri-,tetanus-, acellulære kikhoste- og polioantigener NO2006005I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623233.5A GB9623233D0 (en) 1996-11-07 1996-11-07 Vaccine composition
PCT/EP1997/006180 WO1998019702A1 (en) 1996-11-07 1997-11-04 Acellular pertussis vaccine with diphthriae- and tetanus-toxoids

Publications (2)

Publication Number Publication Date
NO2006005I1 NO2006005I1 (no) 2006-05-08
NO2006005I2 true NO2006005I2 (no) 2010-04-12

Family

ID=10802615

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19992156A NO320186B1 (no) 1996-11-07 1999-05-04 Vaksinesammensetning omfattende difteri-, tetanus- og acellulaere kikhosteantigener, og anvendelse av denne for fremstilling av et medikament for behandling og forebyggelse av Bordetella pertussis infeksjoner.
NO2006005C NO2006005I2 (no) 1996-11-07 2006-04-25 Difteri-,tetanus-, acellulære kikhoste- og polioantigener

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19992156A NO320186B1 (no) 1996-11-07 1999-05-04 Vaksinesammensetning omfattende difteri-, tetanus- og acellulaere kikhosteantigener, og anvendelse av denne for fremstilling av et medikament for behandling og forebyggelse av Bordetella pertussis infeksjoner.

Country Status (30)

Country Link
EP (2) EP1240905B3 (no)
JP (1) JP3980652B2 (no)
KR (1) KR100518044B1 (no)
CN (1) CN1130226C (no)
AR (1) AR011509A1 (no)
AT (2) ATE222773T1 (no)
AU (1) AU710475B2 (no)
BR (2) BRPI9712917B8 (no)
CA (1) CA2271008C (no)
CO (1) CO4910171A1 (no)
CY (2) CY2407B1 (no)
CZ (1) CZ295954B6 (no)
DE (3) DE69715031T2 (no)
DK (2) DK0941117T3 (no)
ES (2) ES2182131T3 (no)
GB (1) GB9623233D0 (no)
HK (2) HK1022638A1 (no)
HU (1) HU224126B1 (no)
IL (1) IL129530A (no)
LU (1) LU91183I2 (no)
NO (2) NO320186B1 (no)
NZ (1) NZ335384A (no)
PL (1) PL188460B1 (no)
PT (2) PT941117E (no)
SA (1) SA98181128B1 (no)
SI (2) SI0941117T1 (no)
TR (1) TR199900979T2 (no)
TW (1) TW471971B (no)
WO (1) WO1998019702A1 (no)
ZA (1) ZA979984B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004314A1 (fr) * 1998-11-26 2000-05-31 Pasteur Merieux MSD Vaccin T.d. Polio rappel pour une population vaccinée ou sensibilisée
KR100374813B1 (ko) * 2000-04-07 2003-03-03 녹십자백신 주식회사 디프테리아, 파상풍 톡소이드, 정제백일해 및비형간염표면항원을 포함한 4가 혼합백신 및 그 제조 방법
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP5007425B2 (ja) * 2006-01-30 2012-08-22 財団法人ヒューマンサイエンス振興財団 百日咳ワクチンの安全性評価方法
GB0616306D0 (en) * 2006-08-16 2006-09-27 Novartis Ag Vaccines
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
CN102844047B (zh) 2009-09-02 2017-04-05 诺华股份有限公司 含tlr活性调节剂的免疫原性组合物
US20120177681A1 (en) 2010-09-01 2012-07-12 Manmohan Singh Formulation of immunopotentiators
CA2828844C (en) 2011-03-02 2020-07-14 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
CN102363041A (zh) * 2011-11-17 2012-02-29 成都欧林生物科技股份有限公司 不含防腐剂疫苗的制作工艺
WO2013132041A2 (en) 2012-03-08 2013-09-12 Novartis Ag Adjuvanted formulations of booster vaccines
CN102793915B (zh) * 2012-07-25 2013-10-23 天津康希诺生物技术有限公司 一种无细胞百日咳疫苗的生产方法
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
CN103100081A (zh) * 2012-12-26 2013-05-15 天津康希诺生物技术有限公司 一种多价联合疫苗
ES2597832T3 (es) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Vacuna acelular contra la tosferina
CA2919773A1 (en) 2013-08-05 2015-02-12 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions
CN114748616A (zh) * 2022-05-23 2022-07-15 中国医学科学院医学生物学研究所 一种成人青少年用无细胞百白破联合疫苗及其制备方法
CN117417419B (zh) * 2023-01-10 2024-04-19 康希诺生物股份公司 一种百日咳毒素脱毒方法及无细胞百白破联合疫苗

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI861417A0 (fi) 1985-04-15 1986-04-01 Endotronics Inc Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav.
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
EP0304578B1 (en) 1987-06-22 2001-10-24 Medeva Holdings Bv Peptide comprising hepatitis B surface antigen
DE3789866T2 (de) 1987-07-17 1994-09-22 Rhein Biotech Proz & Prod Gmbh DNA-Moleküle, die für FMDH-Kontrollabschnitte und Strukturgene für ein Protein mit FMDH-Aktivität kodieren, sowie deren Anwendung.
SG48175A1 (en) 1989-07-25 1998-04-17 Smithkline Beecham Biolog Novel antigens and method for their preparation
GB9007024D0 (en) 1990-03-29 1990-05-30 Imperial College Novel vaccine
HU220236B (hu) 1992-05-23 2001-11-28 Smithkline Beecham Biologicals S.A. Hepatitis B felszíni antigént és egyéb antigéneket tartalmazó, kombinált oltóanyagok

Also Published As

Publication number Publication date
EP1240905B3 (en) 2009-08-26
HK1050473B (zh) 2006-03-03
EP1240905B1 (en) 2005-05-11
HK1022638A1 (en) 2000-08-18
ES2182131T3 (es) 2003-03-01
ATE222773T1 (de) 2002-09-15
HU224126B1 (hu) 2005-05-30
PL333127A1 (en) 1999-11-22
DE69733285T3 (de) 2010-03-25
TR199900979T2 (xx) 1999-07-21
NO992156L (no) 1999-05-04
DE69715031D1 (de) 2002-10-02
DK1240905T5 (da) 2010-01-11
NO2006005I1 (no) 2006-05-08
CY2407B1 (en) 2004-09-10
ES2240647T7 (es) 2010-03-31
DE69715031T2 (de) 2003-05-08
BR9712917A (pt) 1999-12-07
PL188460B1 (pl) 2005-02-28
IL129530A (en) 2005-11-20
JP3980652B2 (ja) 2007-09-26
CN1130226C (zh) 2003-12-10
BRPI9712917B1 (pt) 2019-12-03
NO320186B1 (no) 2005-11-07
AR011509A1 (es) 2000-08-30
NO992156D0 (no) 1999-05-04
JP2001503422A (ja) 2001-03-13
DE69733285T2 (de) 2006-01-12
ZA979984B (en) 1998-07-23
HUP9904287A3 (en) 2001-05-28
CN1236321A (zh) 1999-11-24
ATE295178T1 (de) 2005-05-15
CA2271008C (en) 2008-07-22
DE69733285D1 (de) 2005-06-16
CZ164099A3 (cs) 1999-10-13
DE122005000046I1 (de) 2005-12-29
TW471971B (en) 2002-01-11
CZ295954B6 (cs) 2005-12-14
DK1240905T3 (da) 2005-07-18
WO1998019702A1 (en) 1998-05-14
AU710475B2 (en) 1999-09-23
ES2240647T3 (es) 2005-10-16
SI1240905T1 (en) 2005-10-31
KR100518044B1 (ko) 2005-09-30
AU5319698A (en) 1998-05-29
BRPI9712917B8 (pt) 2021-05-25
SA98181128B1 (ar) 2006-03-25
DK0941117T3 (da) 2002-11-18
EP1240905A1 (en) 2002-09-18
SI0941117T1 (en) 2002-12-31
CO4910171A1 (es) 2000-04-24
PT941117E (pt) 2002-12-31
HUP9904287A1 (hu) 2000-04-28
NZ335384A (en) 2000-10-27
PT1240905E (pt) 2005-09-30
GB9623233D0 (en) 1997-01-08
LU91183I2 (fr) 2005-09-20
EP0941117A1 (en) 1999-09-15
CA2271008A1 (en) 1998-05-14
HK1050473A1 (en) 2003-06-27
CY2568B1 (en) 2008-07-02
EP0941117B1 (en) 2002-08-28
KR20000053092A (ko) 2000-08-25
IL129530A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
NO2006005I2 (no) Difteri-,tetanus-, acellulære kikhoste- og polioantigener
NO20026175D0 (no) Vaksinesammensetning
EP0845270A4 (en) FUNCTIONAL FRAGMENT ANTIGEN OF TETANUS TOXIN, AND TETANUS VACCINE
ATE188508T1 (de) Impfstoffe gegen diphtherietoxin
GB9713156D0 (en) Vaccines
ATE339965T1 (de) Vielwertige dtp-polio-impfstoffe
EP1309602A4 (en) MALARIA IMMUNOGEN AND VACCINE
KR970704468A (ko) 폴리에피토프 백신(polyepitope vaccines)
ZA200207002B (en) Salmonella vaccine materials and methods.
IL149471A0 (en) Vaccines for mycoplasma bovis and methods for immunizing bovine amimals
ZA9710205B (en) Bacterial antigens and vaccine compositions II.
IL115521A0 (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
DK1027895T3 (da) Erysipelothrix rhusiopathiae-antigener og vaccinepræparater
ID20908A (id) Antigen fragmen fungsional toksin tetanus dan vaksin tetanus
IT240087Y1 (it) Ritrovato per allungamento e/o rinfoltimento dei capelli bivalente:come allungamento rapido e temporaneo, oppure stabile e permanente.
ZA200301175B (en) Malaria immunogen and vaccine.